Inventiva S.A. (IVEVF) Financials

IVEVF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2025 210.9 million 221.4 million
March 31, 2025 128.7 million 244.1 million
Dec. 31, 2024 123.9 million 234.9 million
Sept. 30, 2024 43.9 million 131.9 million

IVEVF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2025 -63.4 million 9.4 million
March 31, 2025 ? ?
Dec. 31, 2024 -89.8 million 3.7 million
Sept. 30, 2024 ? ?

IVEVF Net Income

No data available :(

IVEVF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2025 172.9 million 60.8 million 4.7 million
March 31, 2025 104.5 million - -
Dec. 31, 2024 100.6 million 48.2 million 4.8 million
Sept. 30, 2024 11.3 million - -

IVEVF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2025 128.3 million
March 31, 2025 ?
Dec. 31, 2024 70.4 million
Sept. 30, 2024 57.9 million

IVEVF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2025 67183 52.9 million 17.9 million 869852
March 31, 2025 - - - -
Dec. 31, 2024 346764 45.9 million 10.5 million 1.4 million
Sept. 30, 2024 - 26.1 million 4.3 million 332976

IVEVF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2025 6.6 million 63647
March 31, 2025 - -
Dec. 31, 2024 12.5 million 547742
Sept. 30, 2024 1.5 million -

IVEVF

Price: $5.33

52 week price:
2.28
5.75

Earnings Per Share: -2.20 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 741.2 million

Links: